177 related articles for article (PubMed ID: 20669226)
61. Clinicopathologic and prognostic factors of thymoma in Tunisia.
Braham E; Kilani T; El Mezni F
Tunis Med; 2016 Feb; 94(2):118-22. PubMed ID: 27532527
[TBL] [Abstract][Full Text] [Related]
62. Thymoma: a multivariate analysis of factors predicting survival.
Blumberg D; Port JL; Weksler B; Delgado R; Rosai J; Bains MS; Ginsberg RJ; Martini N; McCormack PM; Rusch V
Ann Thorac Surg; 1995 Oct; 60(4):908-13; discussion 914. PubMed ID: 7574993
[TBL] [Abstract][Full Text] [Related]
63. Survival and treatments in patients with incompletely resected thymoma.
Hamaji M; Omasa M; Chen F; Yamada T; Sato M; Menju T; Sato T; Aoyama A; Sonobe M; Bando T; Date H
Asian Cardiovasc Thorac Ann; 2014 Jul; 22(6):712-8. PubMed ID: 24887927
[TBL] [Abstract][Full Text] [Related]
64. Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia).
Zaman M; Huissoon A; Buckland M; Patel S; Alachkar H; Edgar JD; Thomas M; Arumugakani G; Baxendale H; Burns S; Williams AP; Jolles S; Herriot R; Sargur RB; Arkwright PD
Clin Exp Immunol; 2019 Jan; 195(1):132-138. PubMed ID: 30216434
[TBL] [Abstract][Full Text] [Related]
65. Influence of Smoking and Histologic Subtype on Developing Extrathymic Malignancy in Thymoma Patients.
Yanagiya M; Matsumoto J; Kawahara T; Yamaguchi H; Nagayama K; Anraku M; Sato M; Nakajima J
Ann Thorac Surg; 2019 May; 107(5):1532-1539. PubMed ID: 30576633
[TBL] [Abstract][Full Text] [Related]
66. Association of clinical and pathological variables with survival in thymoma.
Aydiner A; Toker A; Sen F; Bicakci E; Saglam EK; Erus S; Eralp Y; Tas F; Oral EN; Topuz E; Dilege S
Med Oncol; 2012 Sep; 29(3):2221-8. PubMed ID: 22057358
[TBL] [Abstract][Full Text] [Related]
67. Treatment and prognosis of type B2 thymoma.
Song Z; Jin X; Zhang Y
World J Surg Oncol; 2014 Sep; 12():291. PubMed ID: 25240293
[TBL] [Abstract][Full Text] [Related]
68. Modified maximal thymectomy for thymic epithelial tumors: predictors of survival and neurological outcome in patients with thymomatous myasthenia gravis.
Prokakis C; Koletsis E; Apostolakis E; Zolota V; Chroni E; Baltayiannis N; Chatzimichalis A; Dougenis D
World J Surg; 2009 Aug; 33(8):1650-8. PubMed ID: 19506940
[TBL] [Abstract][Full Text] [Related]
69. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study.
Fallah M; Liu X; Ji J; Försti A; Sundquist K; Hemminki K
Ann Oncol; 2014 Oct; 25(10):2025-2030. PubMed ID: 25081899
[TBL] [Abstract][Full Text] [Related]
70. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
71. Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period.
Chen CY; Lai CH; Lee KD; Huang SH; Dai YM; Chen MC
Gynecol Oncol; 2012 Dec; 127(3):625-30. PubMed ID: 22975362
[TBL] [Abstract][Full Text] [Related]
72. [Surgical treatment of thymomas in patients with generalized myasthenia gravis].
Vetshev PS; Ippolitov LI; Merkulova DM; Zhivotov VA; Ponomarev AB
Khirurgiia (Mosk); 2003; (10):15-20. PubMed ID: 14597950
[TBL] [Abstract][Full Text] [Related]
73. Iterative Surgical Treatment for Repeated Recurrences After Complete Resection of Thymic Tumors.
Fiorelli A; D'Andrilli A; Vanni C; Cascone R; Anile M; Diso D; Tassi V; Vannucci J; Serra N; Puma F; Rendina EA; Venuta F; Santini M
Ann Thorac Surg; 2017 Feb; 103(2):422-431. PubMed ID: 27825684
[TBL] [Abstract][Full Text] [Related]
74. Thymoma: prognostic factors.
Etienne T; Deleaval PJ; Spiliopoulos A; Megevand R
Eur J Cardiothorac Surg; 1993; 7(9):449-52. PubMed ID: 8217222
[TBL] [Abstract][Full Text] [Related]
75. Extrathymic malignancies in thymoma patients with and without myasthenia gravis.
Owe JF; Cvancarova M; Romi F; Gilhus NE
J Neurol Sci; 2010 Mar; 290(1-2):66-9. PubMed ID: 20034637
[TBL] [Abstract][Full Text] [Related]
76. Incidence of Benign and Malignant Tumors in Patients With Acromegaly Is Increased: A Nationwide Population-based Study.
Esposito D; Ragnarsson O; Johannsson G; Olsson DS
J Clin Endocrinol Metab; 2021 Nov; 106(12):3487-3496. PubMed ID: 34343297
[TBL] [Abstract][Full Text] [Related]
77. [Application of Postoperative Chemotherapy on Thymomas and Its Prognostic Effect].
Ma K; Gu Z; Han Y; Fu J; Shen Y; Wei Y; Tan L; Zhang P; Chen C; Zhang R; Li Y; Chen KN; Chen H; Liu Y; Cui Y; Wang Y; Pang L; Yu Z; Zhou X; Liu Y; Liu Y; Fang W;
Zhongguo Fei Ai Za Zhi; 2016 Jul; 19(7):473-82. PubMed ID: 27339725
[TBL] [Abstract][Full Text] [Related]
78. Multimodality treatment of thymoma: a prospective study.
Venuta F; Rendina EA; Pescarmona EO; De Giacomo T; Vegna ML; Fazi P; Flaishman I; Guarino E; Ricci C
Ann Thorac Surg; 1997 Dec; 64(6):1585-91; discussion 1591-2. PubMed ID: 9436540
[TBL] [Abstract][Full Text] [Related]
79. Radiation therapy of invasive thymoma.
Arakawa A; Yasunaga T; Saitoh Y; Uozumi H; Takada C; Baba Y; Yoshizumi K; Takahashi M
Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):529-34. PubMed ID: 2180868
[TBL] [Abstract][Full Text] [Related]
80. Thymoma and autoimmunity.
Shelly S; Agmon-Levin N; Altman A; Shoenfeld Y
Cell Mol Immunol; 2011 May; 8(3):199-202. PubMed ID: 21317916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
